Qiagen N.V., a Netherlands-based medical diagnostics provider, faces market pressure due to some recent NIH funding concerns, despite strong financials and a diverse product portfolio. The company ...
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it has filed a complaint against bioMérieux S.A. (EPA: BIM) for patent ...
(RTTNews) - QIAGEN N.V. (QGEN) announced that it has filed a complaint against bioMrieux S.A. for patent infringement, reinforcing its commitment to protecting the scientific advancements behind ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Monday, shares of Qiagen NV (Symbol: QGEN) entered into oversold territory, hitting an RSI reading of 29.8 ...
Qiagen N.V. offers sample to insight solutions that transform biological materials into molecular insights. The company provides sample technology consumables, such as nucleic stabilization and ...
After hours: March 14 at 5:05:00 PM EDT Loading Chart for QGEN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results